Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival.
about
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusBRCA-associated ovarian cancer: from molecular genetics to risk managementDiffering clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancerFrontiers in Suicide Gene Therapy of Cancer.Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance.High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy.Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer.Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy.Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.
P2860
Q28307436-5B2CD3CA-35C2-4D48-AE80-29C0C1B03FCDQ34032766-9D6A3567-C618-462E-9255-9FDDDF44FFA4Q34305493-1D7A1DF5-615A-4E45-8F68-958EB6DFE1B8Q34766184-51760DF5-0D58-458F-80A0-1F8DC76A69BEQ36534930-E86530E0-BB51-42CC-AA14-1188D4A1885BQ36979335-03344DBB-B124-4D34-B7E5-02C7EE665BA9Q37598303-3BB7C6CD-0E62-4F2C-9E8E-C99A91718CB9Q37651305-14DC7D4E-AE3C-416D-B147-751DB4917CB5Q39309080-C8D1AC18-F2D0-4415-90BC-78EC4DB8D1E4Q39382941-6184AD45-3767-4344-A816-FE53F0B14F54Q40035188-670AAF0A-0279-4D3D-9A58-FAB2393E4341Q41218646-F430943C-9D24-41E4-A3A4-AD9DF5570257Q47160372-FE0C2CBC-54E0-48A9-9DE5-7D3661B2E9F1Q49704608-628B2740-83F7-487E-AAB2-E9E78A7DB9D6Q55041688-F00C0664-4955-4901-B420-F2AB08C7A588Q55377222-277ECA39-A23B-41D9-86CE-3BD543F138EA
P2860
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical characteristics and o ...... cancer: genotype and survival.
@ast
Clinical characteristics and o ...... cancer: genotype and survival.
@en
type
label
Clinical characteristics and o ...... cancer: genotype and survival.
@ast
Clinical characteristics and o ...... cancer: genotype and survival.
@en
prefLabel
Clinical characteristics and o ...... cancer: genotype and survival.
@ast
Clinical characteristics and o ...... cancer: genotype and survival.
@en
P2093
P2860
P1433
P1476
Clinical characteristics and o ...... cancer: genotype and survival.
@en
P2093
Judy E Garber
Linda Steele
Mihaela C Cristea
Nadine Tung
Paul Frankel
Sharon Sand
Ursula Matulonis
Verena Engelstaedter
P2860
P356
10.1016/J.CANCERGEN.2012.01.008
P577
2012-01-01T00:00:00Z